Journal article

PATINA: A randomized, open label, phase III trial to evaluate the efficacy and safety of palbociclib Anti-HER2 therapy endocrine therapy (ET) vs. anti-HER2 therapy ET after induction treatment for hormone receptor positive (HR )/HER2-positive metastatic breast cancer (MBC)

S Loibl, O Metzger, SJ Mandrekar, C Mundhenke, S Seiler, P Valagussa, A DeMichele, E Lim, D Tripathy, EP Winer, C Huang, L Carey, P Francis, KD Miller, MP Goetz, A Prat, S Loi, I Krop, L Gianni, EM Ciruelos

Annals of Oncology | Published : 2018